Identidade

Entecavir Impurity 44

Não indicado · C17H22ClN5O4

01Identidade

Lazychem IDLC-40130
CAS RNNão indicado
PubChem CID56652930
Molecular formulaC17H22ClN5O4
Molecular weight395.8 g/mol
IUPAC nametert-butyl N-[6-chloro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]purin-2-yl]carbamate
InChIKeyKWCLFRSKTVJCQY-DCAQKATOSA-N

02Estrutura e estereoquímica

Two-dimensional chemical structure of Entecavir Impurity 44
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 3 rings, includes aromatic atoms, includes aliphatic carbon, has 3 defined stereocentres, contains at least one halogen atom. These statements are calculated from the published structure string.

Defined stereocentres3
Ring count3
Secondary amines0
Tertiary amines0
SMILESCC(C)(C)OC(=O)NC1=NC2=C(C(=N1)Cl)N=CN2[C@H]3C[C@@H]([C@H](C3=C)CO)O
InChINão indicado

03Stereochemistry

The published structure contains 3 defined and 0 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres3Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 8Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Estado na Índia

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Nomes e relações

API e fármaco de origem

Não indicado

Nomes e relações

    06Fontes